2BB score and signals
Dianthus Therapeutics, Inc.’s current 2BB score is 22 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 41 | Moderate |
| Momentum | 18 | Strongly Weakening |
| Financial strength | 21 | Weak |
| Quality | 80 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Founded | 2019 |
| Employees | 92 |
| 52-week range | $22.81 – $117.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -1.0114 | — | $342,128.00 |
| 2026-08-06 | — | -0.8748 | — | $263,751.00 |
| 2026-05-05 | -0.85 | -1.0936 | $463,000.00 | $361,294.00 |
| 2026-03-09 | -1.43 | -1.0972 | $284,000.00 | $406,898.00 |
Related companies
2BBBullish & Bearish